Skip to content

Effects of pretreatment with remifentanil on sufentanil-induced cough during induction of general anesthesia

Effects of pretreatment with remifentanil on sufentanil-induced cough during induction of general anesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098291
Enrollment
Unknown
Registered
2025-03-05
Start date
2025-03-20
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sufentanil-induced cough during induction of general anesthesia

Interventions

Remifentanil group:Preinfusion with 0.1 ug/kg.min remifentanil for 5 minutes
Control group:Preinfusion with 0.1 ug/kg.min normal saline for 5 minutes

Sponsors

Air Force Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 100 ASA physical status I-II patients aged 18 to 65 years, weighing between 40 and 80 kg,and scheduled for elective surgery during general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Body weight exceeding 20% of the ideal body weight; 2. History of liver or kidney impairment; 3. Increased intracranial, intraabdominal or intraocular pressure before operation, depression, smoking, asthma, chronic cough, upper respiratory tract infection within one month of surgery; 4. Use of medications that could interfere with this study such as angiotensin-converting enzyme inhibitors, antidepressants, bronchodilators or steroidsa; 5. History of gastroesopha-geal reflux, hypertension, diabetes, heart disease.

Design outcomes

Primary

MeasureTime frame
Severity of cough;

Secondary

MeasureTime frame
Mean arterial pressure;Heart rate;

Countries

China

Contacts

Public ContactXueyue Zhou

Air Force Medical Center

19913141191@163.com+86 199 1314 1191

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026